Charles River Laboratories International
CRL
Charles River Laboratories International (CRL) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $300.00 from $235.00 | Aug 10, 2026 |
| Morgan Stanley | Maintained | Overweight | $300.00 from $260.00 | Aug 7, 2026 |
| JP Morgan | Upgraded | Neutral → Overweight | $310.00 from $180.00 | Aug 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $300.00 from $260.00 | Aug 6, 2026 |
| RBC Capital | Maintained | Outperform | $282.00 from $215.00 | Aug 6, 2026 |
| CLSA | Downgraded | Outperform → Hold | $219.00 | Jul 20, 2026 |
| Mizuho | Maintained | Neutral | $230.00 from $192.00 | Jul 13, 2026 |
| Morgan Stanley | Maintained | Overweight | $260.00 from $220.00 | Jul 9, 2026 |
| Morgan Stanley | Upgraded | Equal-Weight → Overweight | $220.00 from $185.00 | Jun 17, 2026 |
| CLSA | Upgraded | Hold → Outperform | $219.00 from $167.00 | May 29, 2026 |
| Evercore ISI Group | Maintained | Outperform | $220.00 from $200.00 | May 8, 2026 |
| Barclays | Maintained | Overweight | $220.00 from $210.00 | May 8, 2026 |
| Barclays | Maintained | Overweight | $210.00 from $200.00 | Apr 14, 2026 |
| JP Morgan | Maintained | Neutral | $160.00 from $165.00 | Apr 13, 2026 |
| UBS | Maintained | Neutral | $175.00 from $170.00 | Feb 25, 2026 |
| Mizuho | Maintained | Neutral | $175.00 from $215.00 | Feb 20, 2026 |
| TD Cowen | Maintained | Buy | $235.00 from $251.00 | Feb 20, 2026 |
| Evercore ISI Group | Maintained | Outperform | $200.00 from $260.00 | Feb 19, 2026 |
| Barclays | Maintained | Overweight | $200.00 from $215.00 | Feb 19, 2026 |
| Citigroup | Maintained | Buy | $265.00 from $200.00 | Jan 16, 2026 |
Frequently asked questions
What is the latest analyst rating on CRL?
On Aug 10, 2026, TD Cowen maintained Charles River Laboratories International at Buy with a price target of $300.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.